MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
Clinical trial NCT03418532 · TERMINATED
Trial details
- NCT number
- NCT03418532
- Sponsor
- Molecular Partners AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2019-08-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.